BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34044822)

  • 1. miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.
    Zhang MY; Wang LQ; Chim CS
    Cell Commun Signal; 2021 May; 19(1):62. PubMed ID: 34044822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
    Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
    Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
    Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
    Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Silencing of Tumor Suppressor lncRNA
    Zhang MY; Calin G; Deng MD; Au-Yeung RKH; Wang LQ; Chim CS
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Yim RL; Wong KY; Kwong YL; Loong F; Leung CY; Chu R; Lam WW; Hui PK; Lai R; Chim CS
    Oncotarget; 2014 Oct; 5(20):9770-82. PubMed ID: 25211095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential regulatory role for intronic microRNA-338-3p for its host gene encoding apoptosis-associated tyrosine kinase.
    Kos A; Olde Loohuis NF; Wieczorek ML; Glennon JC; Martens GJ; Kolk SM; Aschrafi A
    PLoS One; 2012; 7(2):e31022. PubMed ID: 22363537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.
    Chim CS; Wong KY; Leung CY; Chung LP; Hui PK; Chan SY; Yu L
    J Cell Mol Med; 2011 Dec; 15(12):2760-7. PubMed ID: 21323860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of the MIR129-2 in hematological malignancies.
    Wong KY; Yim RL; Kwong YL; Leung CY; Hui PK; Cheung F; Liang R; Jin DY; Chim CS
    J Hematol Oncol; 2013 Feb; 6():16. PubMed ID: 23406679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
    Wang LQ; Wong KY; Rosèn A; Chim CS
    Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chim CS
    J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of the miR-124-1 in haematological malignancies.
    Wong KY; So CC; Loong F; Chung LP; Lam WW; Liang R; Li GK; Jin DY; Chim CS
    PLoS One; 2011 Apr; 6(4):e19027. PubMed ID: 21544199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.
    Zhang Z; Dai DQ
    World J Gastroenterol; 2019 Mar; 25(10):1224-1237. PubMed ID: 30886505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostification.
    Wang LQ; Kumar S; Calin GA; Li Z; Chim CS
    Br J Haematol; 2020 Jul; 190(2):249-261. PubMed ID: 32079038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphoma.
    Wang QM; Lian GY; Song Y; Peng ZD; Xu SH; Gong Y
    Cancer Gene Ther; 2019 Jul; 26(7-8):195-207. PubMed ID: 30470842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-204-5p acts as tumor suppressor to influence the invasion and migration of astrocytoma by targeting ezrin and is downregulated by DNA methylation.
    Jiang H; Ge R; Chen S; Huang L; Mao J; Sheng L
    Bioengineered; 2021 Dec; 12(2):9301-9312. PubMed ID: 34723710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
    Gao W; Gu Y; Li Z; Cai H; Peng Q; Tu M; Kondo Y; Shinjo K; Zhu Y; Zhang J; Sekido Y; Han B; Qian Z; Miao Y
    Oncogene; 2015 Mar; 34(13):1629-40. PubMed ID: 24769899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1.
    Ni J; Tian W; Liang S; Wang H; Ren Y
    Int J Med Sci; 2021; 18(12):2510-2520. PubMed ID: 34104082
    [No Abstract]   [Full Text] [Related]  

  • 20. Epigenetic silencing of EVL/miR-342 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chng WJ; Chim CS
    Transl Res; 2018 Feb; 192():46-53. PubMed ID: 29242101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.